Gilead to fork over $1.25B, pay 3% royalty on blockbuster Biktarvy in GSK patent settlement esagonowsky Tue, 02/01/2022 – 16:28 More: Gilead to fork over .25B, pay 3% royalty on blockbuster Biktarvy in GSK patent settlement Source: fierce
read moreShkreli and Vyera settle for $28M in yet another Daraprim antitrust suit fkansteiner Tue, 02/01/2022 – 14:39 More: Shkreli and Vyera settle for M in yet another Daraprim antitrust suit Source: fierce
read moreGlaxoSmithKline’s HIV drug Cabenuva scores FDA nod for 2-month dosing kdunleavy Tue, 02/01/2022 – 11:22 More: GlaxoSmithKline's HIV drug Cabenuva scores FDA nod for 2-month dosing Source: fierce
read moreNovartis’ Sandoz reportedly the target of $25B buyout bid from Carlyle and Blackstone fkansteiner Tue, 02/01/2022 – 11:09 More: Novartis' Sandoz reportedly the target of B buyout bid from Carlyle and Blackstone Source: fierce
read moreNovartis, Amgen settle their dueling lawsuits over migraine drug Aimovig esagonowsky Tue, 02/01/2022 – 10:36 More: Novartis, Amgen settle their dueling lawsuits over migraine drug Aimovig Source: fierce
read moreAyvakyt receives a positive opinion from the CHMP for the treatment of adults with advanced systemic mastocytosis More: Broadening horizons: positive CHMP opinion for expanding Ayvakyt Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals